Targeting the Top 20 Cancers | GenomeWeb

Targeting the Top 20 Cancers


With so much talk about methylation and biomarkers, the two still have a way to go before they’re paired in a commercially successful test to predict or prevent cancer. However, six years into a project that aims to have an early detection biomarker test for the top 20 most deadly cancers in the US, Northwestern University’s Victor Levenson is getting there step by step.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.